U.S. Buys $290M Worth of Anti-Radiation Drugs Amid Nuclear War Fears

nuclear-war-fears-cnbc-com-2022-truth


AD - Trump Diamond Bucks - Support Trump With High Quality Dollar Merchandise - Click Here - Order Today

U.S. Department of Health and Human Services is purchasing a supply of the drug Nplate from Amgen USA Inc; Nplate is approved to treat blood cell injuries that accompany acute radiation syndrome

U.S. Buys $290M Worth of Anti-Radiation Drugs Amid Nuclear War Fears

Sean Adl-Tabatabai with NewsPunch reports:

nuclear-war-fears-cnbc-com-2022-truth
IMAGE VIA cnbc.com

The Biden administration is buying up $290 million in anti-radiation drugs for use in an imminent “nuclear war” amid escalating tensions with Russia.

The Department of Health and Human Services issued the following Press Release:


earn free bitcoin

HHS purchases drug for use in radiological and nuclear emergencies

As part of long-standing, ongoing efforts to be better prepared to save lives following radiological and nuclear emergencies, the U.S. Department of Health and Human Services is purchasing a supply of the drug Nplate from Amgen USA Inc; Nplate is approved to treat blood cell injuries that accompany acute radiation syndrome in adult and pediatric patients (ARS).

Amgen, based in Thousands Oaks, California, developed Nplate for ARS with support from the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Administration for Strategic Preparedness and Response (ASPR), as well as the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

BARDA is using its authority provided under the 2004 Project Bioshield Act and $290 million in Project BioShield designated funding to purchase this supply of the drug. Amgen will maintain this supply in vendor-managed inventory. This approach decreases life-cycle management costs for taxpayers because doses that near expiration can be rotated into the commercial market for rapid use prior to expiry and new doses can be added to the government supply.

ARS, also known as radiation sickness, occurs when a person’s entire body is exposed to a high dose of penetrating radiation, reaching internal organs in a matter of seconds. Symptoms of ARS injuries include impaired blood clotting as a result of low platelet counts, which can lead to uncontrolled and life-threatening bleeding.

READ THIS  What the Australian Election Says About Australia

To reduce radiation-induced bleeding, Nplate stimulates the body’s production of platelets. The drug can be used to treat adults and children.

Nplate is also approved for adult and pediatric patients with immune thrombocytopenia, a blood disorder resulting in low platelet counts. Repurposing drugs for acute radiation syndrome that also are approved for a commercial indication helps to sustain availability of the product and improves healthcare provider familiarity with the drug.




Please use the buttons to TWEET & SHARE this post ... then leave your thoughts & feelings in the COMMENT SECTION by scrolling down ... finally If you haven't joined TRUTH PREMIUM, what are you waiting for?

CLICK HERE -->I Want Truth Premium

0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
MERRY CHRISTMAS from MIKE LINDELL: Up to 66% Off Mike Lindell's MyPillow Promo Code ETERNAL


Join Our TRUTH INSIDER Email Newsletter For FREE!